Discover B2B companies, suppliers, and manufacturers related to this keyword category
Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases
Navigating the Middle East & Africa to Broaden Patient Access, Faster
Your Leader in Rare Disease and Complex Therapy Programs
brought to you by Informa Connect
Science fiction becoming science fact.
Personalized T-cell therapies for hematologic malignancies and solid tumors.
Inspired by Nature, driven by data, built for humanity.
Redefining cell therapy manufacturing for the allogeneic future.
Akimbo Bio is developing dual CAR/TCR therapies intended for in vivo delivery via lentiviral vectors.
Australia & New Zealand's only not-for-profit collaborative blood cancer research group
Your Bridge from ATMPs Concept to Commercialization
Enabling life-saving therapies with a unique technology for cell engineering
Market Access Today: Your go-to source for the latest insights, trends, and updates in Market Acces, HEOR, HTA, and RWE.
Cellectis is developing life-changing product candidates to target and eradicate cancer cells.
We're on a mission to make regenerative medicine a part of everyday medicine.
Your Leader in Rare Disease and Complex Therapy Programs